Nattovena enters the market to help maintain healthy blood viscosity

A new product supporting circulatory health is entering the market. According to Dr. Maryam Habibi, CEO of Rasta Imen Darou, the supplement NattoVena contains Nattokinase, an enzyme with fibrinolytic properties.

She explained that this enzyme supports normal blood viscosity and contributes to cardiovascular health. As such, regular use of NattoVena can help regulate fibrin levels in the body, thereby promoting healthy blood circulation.

Dr. Habibi further stated that studies have shown nattokinase aids in breaking down fibrin—the main component of blood clots—and may help prevent thrombosis. This makes it particularly beneficial for individuals at risk of clot formation, such as those with a history of deep vein thrombosis or stroke.

She also noted that the nattokinase in this supplement may improve cerebral blood flow, potentially reducing the risk of stroke.

It is worth noting that NattoVena is a product of Arthur Andrew Medical, a reputable U.S.-based manufacturer, and is exclusively distributed in Iran by Rasta Imen Darou, a subsidiary of Hitco Holding.